Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
agilon healthAGL | Open-market buy | 03/09 | 03/11 | 18,448 sh | In footnote | No stated value | +6.9% | |
Benjamin ShakerChief Markets Officer | agilon healthAGL | Open-market buy | 03/09 | 03/11 | 18,448 sh | In footnote | No stated value | +1.3% |
Denise ZamoreChief Legal Officer | agilon healthAGL | Open-market buy | 03/09 | 03/11 | 5,535 sh | In footnote | No stated value | +1.2% |
Benjamin ShakerChief Markets Officer | agilon healthAGL | Open-market buy | 03/02 | 03/03 | 500,000 sh | $0.60 | $300,000 | +57.6% |
John William WulfDirector | agilon healthAGL | Open-market buy | 25/11/12 | 01/30 | 81,000 sh | $0.63 | $51,030 | +28.4% |
agilon healthAGL | Open-market buyAmendment | 23/11/29 | 25/04/03 | 22,300 sh | $11.22 | $250,206 | No record | |
Steven SellCEO & President | agilon healthAGL | Open-market buy | 25/03/14 | 25/03/18 | 42,426 sh | In footnote | No stated value | +12.9% |
agilon healthAGL | Open-market buy | 25/03/14 | 25/03/18 | 9,429 sh | In footnote | No stated value | +6.3% | |
Benjamin ShakerChief Markets Officer | agilon healthAGL | Open-market buy | 25/03/14 | 25/03/18 | 11,786 sh | In footnote | No stated value | +2.6% |
Karen McLoughlinDirector | agilon healthAGL | Open-market buy | 24/12/13 | 24/12/13 | 25,000 sh | $2.20 | $55,000 | +51.9% |
Battaglia SilvanaDirector | agilon healthAGL | Open-market buy | 24/12/11 | 24/12/13 | 25,062 sh | $2.01 | $50,374.62 | +61.0% |
agilon healthAGL | Open-market buy | 24/11/25–24/12/09 | 24/12/11 | 20,000 sh2 trades | $2.25avg. | $45,000 | +51.5% | |
John William WulfDirector | agilon healthAGL | Open-market buy | 24/12/05 | 24/12/11 | 45,000 sh | $2.18 | $98,100 | +27.9% |
Steven SellCEO & President | agilon healthAGL | Open-market buy | 24/09/12 | 24/09/16 | 20,000 sh | $3.36 | $67,200 | +42.0% |
agilon healthAGL | Open-market buy | 24/03/14 | 24/03/18 | 14,945 sh | In footnote | No stated value | +42.5% | |
agilon healthAGL | Open-market buy | 24/03/14 | 24/03/18 | 5,434 sh | In footnote | No stated value | +14.9% | |
Benjamin KornitzerChief Med. & Quality Officer | agilon healthAGL | Open-market buy | 24/03/14 | 24/03/18 | 5,434 sh | In footnote | No stated value | +9.3% |
Benjamin ShakerChief Markets Officer | agilon healthAGL | Open-market buy | 24/03/14 | 24/03/18 | 274,455 sh | In footnote | No stated value | +345.0% |
Veeral DesaiChief Strategy & Dev. Officer | agilon healthAGL | Open-market buy | 24/03/14 | 24/03/18 | 11,956 sh | In footnote | No stated value | +4.0% |
Jeffrey A. SchwanekeDirector | agilon healthAGL | Open-market buy | 23/11/29 | 23/11/30 | 22,300 sh | $11.22 | $250,206 | +231.5% |